Last reviewed · How we verify
Chinese Herb
At a glance
| Generic name | Chinese Herb |
|---|---|
| Also known as | CM |
| Sponsor | Chang Gung Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease (NA)
- Developing a Methodological Framework and a Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines
- A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty (PHASE3)
- Development of an Aptamer-based Lateral Flow Device for Point-of-care Detection of Toxic Chinese Medicine Herbs (ALPTH Project)
- Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET (PHASE4)
- Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma (PHASE1)
- Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. (PHASE2)
- Traditional Chinese Medicine Hand-Foot Soak for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chinese Herb CI brief — competitive landscape report
- Chinese Herb updates RSS · CI watch RSS
- Chang Gung Memorial Hospital portfolio CI